Annual EBIT
-$494.78 M
-$205.10 M-70.80%
December 31, 2023
Summary
- As of February 10, 2025, KRTX annual earnings before interest & taxes is -$494.78 million, with the most recent change of -$205.10 million (-70.80%) on December 31, 2023.
- During the last 3 years, KRTX annual EBIT has fallen by -$426.27 million (-622.19%).
Performance
KRTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$129.59 M
+$6.63 M+4.87%
December 31, 2023
Summary
- As of February 10, 2025, KRTX quarterly earnings before interest & taxes is -$129.59 million, with the most recent change of +$6.63 million (+4.87%) on December 31, 2023.
- Over the past year, KRTX quarterly EBIT has increased by +$6.63 million (+4.87%).
Performance
KRTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$494.78 M
-$44.55 M-9.90%
December 31, 2023
Summary
- As of February 10, 2025, KRTX TTM earnings before interest & taxes is -$494.78 million, with the most recent change of -$44.55 million (-9.90%) on December 31, 2023.
- Over the past year, KRTX TTM EBIT has dropped by -$44.55 million (-9.90%).
Performance
KRTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
KRTX EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -70.8% | +4.9% | -9.9% |
3 y3 years | -622.2% | +4.9% | -9.9% |
5 y5 years | -3214.2% | +4.9% | -9.9% |
KRTX EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | +243.9% | at low | +359.7% | +5.1% | +243.9% | at low |
5 y | 5-year | +1050.3% | at low | +1566.9% | +5.1% | +1092.7% | at low |
alltime | all time | >+9999.0% | at low | >+9999.0% | +5.1% | >+9999.0% | at low |
Karuna Therapeutics EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | -$494.78 M(+70.8%) | -$129.59 M(-4.9%) | -$494.78 M(+9.9%) |
Sep 2023 | - | -$136.22 M(+13.6%) | -$450.23 M(+14.0%) |
Jun 2023 | - | -$119.91 M(+9.9%) | -$395.00 M(+16.1%) |
Mar 2023 | - | -$109.07 M(+28.3%) | -$340.15 M(+17.4%) |
Dec 2022 | -$289.68 M(+101.4%) | -$85.04 M(+5.0%) | -$289.68 M(+24.4%) |
Sep 2022 | - | -$80.99 M(+24.5%) | -$232.83 M(+14.7%) |
Jun 2022 | - | -$65.05 M(+11.0%) | -$203.00 M(+17.7%) |
Mar 2022 | - | -$58.59 M(+107.8%) | -$172.48 M(+19.9%) |
Dec 2021 | -$143.85 M(+110.0%) | -$28.19 M(-44.9%) | -$143.85 M(+5.2%) |
Sep 2021 | - | -$51.17 M(+48.2%) | -$136.76 M(+30.1%) |
Jun 2021 | - | -$34.53 M(+15.2%) | -$105.13 M(+18.9%) |
Mar 2021 | - | -$29.96 M(+42.0%) | -$88.42 M(+29.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2020 | -$68.51 M(+59.3%) | -$21.10 M(+8.1%) | -$68.51 M(+24.2%) |
Sep 2020 | - | -$19.53 M(+9.6%) | -$55.18 M(+23.5%) |
Jun 2020 | - | -$17.82 M(+77.3%) | -$44.69 M(+7.7%) |
Mar 2020 | - | -$10.05 M(+29.3%) | -$41.48 M(-3.6%) |
Dec 2019 | -$43.01 M(+188.1%) | -$7.77 M(-14.0%) | -$43.01 M(-0.8%) |
Sep 2019 | - | -$9.04 M(-38.2%) | -$43.37 M(+10.5%) |
Jun 2019 | - | -$14.62 M(+26.2%) | -$39.25 M(+58.4%) |
Mar 2019 | - | -$11.58 M(+42.4%) | -$24.78 M(+68.1%) |
Dec 2018 | -$14.93 M(+207.1%) | -$8.14 M(+65.6%) | -$14.74 M(+123.3%) |
Sep 2018 | - | -$4.91 M(+3242.9%) | -$6.60 M(+291.3%) |
Jun 2018 | - | -$147.00 K(-90.5%) | -$1.69 M(+9.5%) |
Mar 2018 | - | -$1.54 M | -$1.54 M |
Dec 2017 | -$4.86 M | - | - |
FAQ
- What is Karuna Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Karuna Therapeutics?
- What is Karuna Therapeutics annual EBIT year-on-year change?
- What is Karuna Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Karuna Therapeutics?
- What is Karuna Therapeutics quarterly EBIT year-on-year change?
- What is Karuna Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Karuna Therapeutics?
- What is Karuna Therapeutics TTM EBIT year-on-year change?
What is Karuna Therapeutics annual earnings before interest & taxes?
The current annual EBIT of KRTX is -$494.78 M
What is the all time high annual EBIT for Karuna Therapeutics?
Karuna Therapeutics all-time high annual earnings before interest & taxes is -$4.86 M
What is Karuna Therapeutics annual EBIT year-on-year change?
Over the past year, KRTX annual earnings before interest & taxes has changed by -$205.10 M (-70.80%)
What is Karuna Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of KRTX is -$129.59 M
What is the all time high quarterly EBIT for Karuna Therapeutics?
Karuna Therapeutics all-time high quarterly earnings before interest & taxes is -$147.00 K
What is Karuna Therapeutics quarterly EBIT year-on-year change?
Over the past year, KRTX quarterly earnings before interest & taxes has changed by +$6.63 M (+4.87%)
What is Karuna Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of KRTX is -$494.78 M
What is the all time high TTM EBIT for Karuna Therapeutics?
Karuna Therapeutics all-time high TTM earnings before interest & taxes is -$1.54 M
What is Karuna Therapeutics TTM EBIT year-on-year change?
Over the past year, KRTX TTM earnings before interest & taxes has changed by -$44.55 M (-9.90%)